(This story first appeared at reMind, a psychedelics business platform. The reMind Psychedelics Business Forum is Dec. 3 at MJBizCon. Full information about the forum is available here.)
New Jersey lawmakers are hoping to succeed with psychedelics policy reform in ways their counterparts in California and Connecticut have not – at least not so far.
While Colorado, Oregon and now Massachusetts asked voters to decide whether to legalize psychedelic medicines, the Garden State is pursuing legislative action.
ADVERTISEMENT
The Psilocybin Behavioral Health Access and Services Act, sponsored by New Jersey state Sens. Nick Scutari and Joe Vitale, would create a legal framework for psilocybin cultivation, manufacturing, testing and administration as part of a therapeutic-access model.
The bill was reintroduced in the Legislature in January and
Read full article on Marijuana Business Daily
